MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy boosts bladder cancer fight before surgery
Disease control Not yet recruitingThis phase 2 trial tests whether adding a gene therapy (nadofaragene firadenovec) to standard chemotherapy and immunotherapy before bladder removal can improve outcomes for people with muscle-invasive bladder cancer. About 33 adults will receive the combination, then have their b…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New combo aims to spare bladder in tough-to-treat cancer
Disease control Not yet recruitingThis study tests whether a combination of targeted therapy (RC48-ADC) and immunotherapy (toripalimab) plus radiation can help people with HER2-positive muscle-invasive bladder cancer avoid bladder removal. About 45 adults who have already had chemotherapy will receive the drug co…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 19, 2026 11:47 UTC